Tagworks Pharmaceuticals is a privately held biotech company based in the Netherlands. The company is developing a unique and proprietary Click-to-Release platform to enable selective release of anticancer drugs in the tumor microenvironment. This platform has a broad set of application areas (antidrug conjugates, radioligands, T cell engagers and cytokines), and has the potential to increase antitumor efficacy while lowering potential toxicity for patients.

Tagworks Pharmaceuticals raised a €60 million Series A financing co-led by Gilde Healthcare to further develop its differentiated click chemistry platform and bring drug candidates to the clinic.